Current HGSOC detection approaches rely on a collection of clinically utilized serum biomarkers that are used for ovarian cancer in general, namely CA125 (carbohydrate antigen 125 or mucin-16) and HE4 (human epididymis protein 4 or WAP four-disulfide core domain protein 2). This evidence concerns the gene WFDC2 and ovarian carcinoma.